These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27932075)

  • 1. Non-enzymatic oxidized metabolite of DHA, 4(RS)-4-F
    Roy J; Fauconnier J; Oger C; Farah C; Angebault-Prouteau C; Thireau J; Bideaux P; Scheuermann V; Bultel-Poncé V; Demion M; Galano JM; Durand T; Lee JC; Le Guennec JY
    Free Radic Biol Med; 2017 Jan; 102():229-239. PubMed ID: 27932075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonenzymatic lipid mediators, neuroprostanes, exert the antiarrhythmic properties of docosahexaenoic acid.
    Roy J; Oger C; Thireau J; Roussel J; Mercier-Touzet O; Faure D; Pinot E; Farah C; Taber DF; Cristol JP; Lee JC; Lacampagne A; Galano JM; Durand T; Le Guennec JY
    Free Radic Biol Med; 2015 Sep; 86():269-78. PubMed ID: 25911196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of 4-F
    Signorini C; De Felice C; Durand T; Galano JM; Oger C; Leoncini S; Ciccoli L; Carone M; Ulivelli M; Manna C; Cortelazzo A; Lee JC; Hayek J
    Free Radic Biol Med; 2018 Feb; 115():278-287. PubMed ID: 29233794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonenzymatic oxygenated metabolite of docosahexaenoic acid, 4(RS)-4-F
    Lee YY; Galano JM; Leung HH; Balas L; Oger C; Durand T; Lee JC
    FEBS Lett; 2020 Jun; 594(11):1797-1808. PubMed ID: 32215916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction.
    Thummasorn S; Apaijai N; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2016 Dec; 34(6):404-414. PubMed ID: 27434747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
    Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
    Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric nanocapsules prevent oxidation of core-loaded molecules: evidence based on the effects of docosahexaenoic acid and neuroprostane on breast cancer cells proliferation.
    Roy J; Oliveira LT; Oger C; Galano JM; Bultel-Poncé V; Richard S; Guimaraes AG; Vilela JM; Andrade MS; Durand T; Besson P; Mosqueira VC; Le Guennec JY
    J Exp Clin Cancer Res; 2015 Dec; 34():155. PubMed ID: 26689718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
    Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating 4-F
    Signorini C; Leoncini S; Durand T; Galano JM; Guy A; Bultel-Poncé V; Oger C; Lee JC; Ciccoli L; Hayek J; De Felice C
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive thermopreconditioning attenuates rat cardiac ischemia/reperfusion injury by mitochondria-mediated antioxidant and antiapoptotic mechanisms.
    Chien CY; Chien CT; Wang SS
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):705-13. PubMed ID: 24507988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-ischaemic mitochondrial substrate constraint by inhibition of malate-aspartate shuttle preserves mitochondrial function after ischaemia-reperfusion.
    Jespersen NR; Yokota T; Støttrup NB; Bergdahl A; Paelestik KB; Povlsen JA; Dela F; Bøtker HE
    J Physiol; 2017 Jun; 595(12):3765-3780. PubMed ID: 28093764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
    Lu N; Sun Y; Zheng X
    Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo hyperoxic preconditioning protects against rat-heart ischemia/reperfusion injury by inhibiting mitochondrial permeability transition pore opening and cytochrome c release.
    Petrosillo G; Di Venosa N; Moro N; Colantuono G; Paradies V; Tiravanti E; Federici A; Ruggiero FM; Paradies G
    Free Radic Biol Med; 2011 Feb; 50(3):477-83. PubMed ID: 21130864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.
    Dai W; Cheung E; Alleman RJ; Perry JB; Allen ME; Brown DA; Kloner RA
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):559-566. PubMed ID: 27747447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Effect of Sevoflurane Postconditioning against Cardiac Ischemia/Reperfusion Injury via Ameliorating Mitochondrial Impairment, Oxidative Stress and Rescuing Autophagic Clearance.
    Yu P; Zhang J; Yu S; Luo Z; Hua F; Yuan L; Zhou Z; Liu Q; Du X; Chen S; Zhang L; Xu G
    PLoS One; 2015; 10(8):e0134666. PubMed ID: 26263161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial LonP1 protects cardiomyocytes from ischemia/reperfusion injury in vivo.
    Venkatesh S; Li M; Saito T; Tong M; Rashed E; Mareedu S; Zhai P; Bárcena C; López-Otín C; Yehia G; Sadoshima J; Suzuki CK
    J Mol Cell Cardiol; 2019 Mar; 128():38-50. PubMed ID: 30625302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardioprotectant 3',4'-dihydroxyflavonol inhibits opening of the mitochondrial permeability transition pore after myocardial ischemia and reperfusion in rats.
    Woodman OL; Long R; Pons S; Eychenne N; Berdeaux A; Morin D
    Pharmacol Res; 2014 Mar; 81():26-33. PubMed ID: 24521796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vagus nerve stimulation exerts cardioprotection against myocardial ischemia/reperfusion injury predominantly through its efferent vagal fibers.
    Nuntaphum W; Pongkan W; Wongjaikam S; Thummasorn S; Tanajak P; Khamseekaew J; Intachai K; Chattipakorn SC; Chattipakorn N; Shinlapawittayatorn K
    Basic Res Cardiol; 2018 May; 113(4):22. PubMed ID: 29744667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.